View in EDS

Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.

Saved in:

Bibliographic Details
Title:	Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.
Authors:	Stack, Gary¹ (AUTHOR), Maurice, Carleta B² (AUTHOR)
Source:	American Journal of Clinical Pathology. May2016, Vol. 145 Issue 5, p671-686. 16p.
Database:	Academic Search Ultimate

Description
ISSN:	00029173
DOI:	10.1093/ajcp/aqw049